GA-GSMA
11.6.2019 16:02:06 CEST | Business Wire | Press release
The GSMA announced the first confirmed speakers for the third gathering of MWC19 Los Angeles taking place October 22-24, 2019 at the Los Angeles Convention Center. The GSMA also released additional event details including new programs, exhibitors and participating companies.
“The mobile industry touches the lives of billions of people around the world, and with the arrival of 5G, it is once again changing consumer behavior and business models across the globe,” said John Hoffman, CEO, GSMA. “MWC19 Los Angeles will showcase a range of transformative use cases of the latest mobile technology across the industry’s vast ecosystem and adjacent sectors, exploring today’s new possibilities.”
Leading Executives to Keynote
The GSMA announced the first global leaders to keynote as part of MWC19 Los Angeles’ three-day conference program including:
- Tess Posner, CEO, AI4ALL
- Meredith Attwell Baker, President and CEO, CTIA
- Niklas Heuveldop, Senior Vice President and Head of Market Area North America, Ericsson
- Mats Granryd, Director General, GSMA
- Kenneth R. Meyers, President and CEO, U.S. Cellular and Chairman, CTIA
- Tami Erwin, Executive Vice President and Group CEO, Verizon Business
- Robert M. Bakish, President and CEO, Viacom
In addition to the keynote program, the MWC19 Los Angeles conference will offer 27 track sessions on transformational technologies under the four main themes of 5G, IoT, AI and Immersive Content. Topic breakouts include:
- 5G : economics, edge computing, industrial IoT, spectrum and network slicing;
- IoT : transportation, collaborative intelligence and security;
- AI : ethics, blockchain, disruptive innovation and data analytics; and
- Immersive Content : AR/VR, live entertainment, content creation, distribution, gaming, sports and entertainment, among other topic areas.
Executives and industry experts confirmed to speak in the conference sessions include:
- Andre Feutsch, CTO, AT&T
- Arvind Purushotham, Managing Director and Global Head of Venture Investing, Citi Ventures
- Darcy Antonellis, CEO, Vubiquity
- Dave O’Flanagan, CEO and Co-Founder, Boxever
- John Saw, CTO, Sprint
- Larry O’Reilly, CEO, ARHT Media
- Mary O'Neill, Vice President Security, Nokia
- Michael Sherwood, Director Information Technology and Chief Innovation Officer, City of Las Vegas
- Scott Casey, CTO, Greystar
- Yvette Martinez, CEO North America, ESL
The “Government and Public Policy” track led by CTIA will feature leading policymakers and industry experts exploring how decisions on spectrum, infrastructure and regulatory policy affect investment and innovation. For more information on the MWC19 Los Angeles conference program, visit: www.mwcamericas.com/conference-programs .
4YFN Startup Event
The 4YFN (Four Years from Now) startup event will span the three-day show and focus on the technology industry’s biggest growth areas of connectivity, media and entertainment, artificial intelligence and Tech4Good, addressing social impact and diversity. The startup event brings together innovative companies and investors, to facilitate future joint ventures and partnerships. A key highlight of the event is the 4YFN Los Angeles Awards, where five finalist startups will compete for the recognition in front of judges and an attendee audience.
The GSMA today announced Karix as a 4YFN Gold Sponsor. For more information on 4YFN, visit: https://www.4yfn.com/los-angeles/ .
First Women4Tech Speakers Announced
The MWC19 Los Angeles Women4Tech Summit, designed to address and reduce the persistent gender gap in the mobile industry, will showcase the companies and best practices that are making gender diversity a business imperative. Women4Tech session topics include the future of female leaders in the U.S.; how to inspire girls and women to join STEM careers; and female entrepreneurship, among others.
The first confirmed Women4Tech speakers include executives from major brands including:
- Shelley Zalis, CEO and Founder, The Female Quotient
- Shruti Jain, Head of Business Development, North America, Google
- Namrata Sharma, Director - Head Semiconductor Market Segment, HCL
For more information on Women4Tech, please visit: https://www.mwclosangeles.com/experiences/women4tech/ .
Additional Participating Companies Announced
The GSMA announced new exhibitors and participating companies for MWC19 Los Angeles, among them Alpha, Altair Semiconductor, AMD, Award Solutions, BadVR, BearingPoint, CBRS Alliance, Couchbase, HCL Technologies, Kraix, Motorola Mobility, OPPO, Remade, Samsung, Smith Micro, Syniverse and Xfinity Mobile.
They join previously announced participating companies Amazon, Amdocs, American Tower, ARM, Cisco, Corning Optical Communications, DARPA, Ericsson, G+D Mobile Security, Gemalto, gsmExchange, Hewlett Packard Enterprises, JMA Wireless, KORE Wireless, Mastercard, Mavenir, Netcracker Technology, Nokia, Qualcomm, Sprint, Synchronoss, T-Mobile, Verizon, VMWare and Xiaomi. For more information on the MWC19 exhibition, visit: www.mwclosangeles.com/exhibition/ .
Partner Program at MWC19 Los Angeles
MWC19 Los Angeles partner programs will offer a broad agenda of learning and networking sessions for attendees across the three days of the show. Partner programs include The Besen Group, Blancco, CBRS, Conduent, Fierce Wireless, Light Reading, Netcracker, Sinch and TIA, while mGage and Netcomm Wireless will present Power Hour sessions. A total of 10 IoT and 5G Talks are confirmed for MWC19 Los Angeles. Today, the GSMA also announced James Brehm as an Affiliate Partner and Award Solutions as the Technology Training Partner.
For more information on MWC19 Los Angeles partner program, visit https://www.mwclosangeles.com/ .
DARPA Spectrum Collaboration Challenge Details Announced
MWC19 Los Angeles will host the live championship event of the U.S. Defense Advanced Research Project Agency’s (DARPA) Spectrum Collaboration Challenge (SC2) on October 23 on the Keynote Stage.
The GSMA today announced Grant Imahara, well known for his work on the hit Discovery series MythBusters and Netflix series White Rabbit Project, will serve as the championship event’s master of ceremonies, providing commentary alongside DARPA and industry experts. Imahara will guide the audience through several stages of the competition, culminating in the high-energy final match-up between top teams to determine the recipient of the $2 million grand prize. The SC2 finale is free to attend and open to all MWC19 Los Angeles attendees as well as the general public. Registration for this featured event will open in July.
For more information on SC2, including DARPA on site at MWC19 Los Angeles visit: www.SpectrumCollaborationChallenge.com/ .
Get Involved at MWC19 Los Angeles
More information on MWC19 Los Angeles, including how to attend, exhibit or sponsor, is available at www.mwclosangeles.com . Follow developments and updates on MWC on Twitter @GSMAEvents using #MWC19, on our LinkedIn MWC page https://www.linkedin.com/showcase/mwclosangeles/ and on Facebook at https://www.facebook.com/MWCLosAngeles/ .
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
About CTIA
CTIA® (www.ctia.org ) represents the U.S. wireless communications industry and the companies throughout the mobile ecosystem that enable Americans to lead a 21st century connected life. The association’s members include wireless carriers, device manufacturers, suppliers as well as apps and content companies. CTIA vigorously advocates at all levels of government for policies that foster continued wireless innovation and investment. The association also coordinates the industry’s voluntary best practices, hosts educational events that promote the wireless industry and co-produces the industry’s leading wireless tradeshow. CTIA was founded in 1984 and is based in Washington, D.C.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190611005129/en/
Contact:
Media Contacts: Ivette López, Public Relations Director, GSMA ilopez@gsma.com 678.429.5066
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
